Australia's Memphasys gains most in 5 weeks on device sale to Indian centre

Memphasys

20/12/2021 02:26

** Shares of medical device maker  MEM.AX  soar as much as
14.6% to A$0.110, on track for their sharpest single-day pct
gain since Nov. 16 
    ** Says Womens Center in Coimbatore, India has placed an
initial order for co's Felix System, an automated device for
separating high-quality sperm from a semen sample for use in
human in vitro fertilisation procedures  urn:newsml:reuters.com:*:nASX4yp4hR
    ** Says Womens Centre determined that Felix-produced embryos
were of equal or better quality to the embryos produced by their
current methods for sperm separation
    ** Says co is pursuing commercial discussions with other IVF
clinics in early markets and is confident of securing further
clinical sales in Q1 2022
    ** Shares hit their highest level since Nov. 23 
    ** Stock down 4% this year, as of last close

 (Reporting by Roushni Nair in Bangalore)
 ((Roushni.Nair@thomsonreuters.com))